Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 13, 2016
A Naphthalimide-Based Cd(2+) Fluorescent Probe with Carbamoylmethyl Groups Working as Chelators and PET-Promoters under Neutral Conditions
Koji Tsukamoto, Shota Shimabukuro, Miyuki Mabuchi, et al.
Infectious Diseases (London, England)
|
August 26, 2017
Utility of estimated glomerular filtration rate based on cystatin C in patients receiving combination antiretroviral therapy including dolutegravir
Shinichi Hikasa, Kyoko Hideta, Shota Shimabukuro, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
December 13, 2021
Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on estimated glomerular filtration rate slope in patients with HIV: A retrospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
International Journal of STD & AIDS
|
August 18, 2018
Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Current HIV Research
|
March 28, 2023
Changes in Leptin to Adiponectin Ratio After Antiretroviral Therapy: A Pilot Observational Study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Journal of Pharmaceutical Health Care and Sciences
|
June 12, 2019
Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
HIV Medicine
|
September 20, 2022
Comparison between the impact of tenofovir alafenamide and that of abacavir on rapid kidney function decline: A retrospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
February 9, 2018
A potential drug interaction between phenobarbital and dolutegravir: A case report
Shinichi Hikasa, Akihiro Sawada, Hitomi Seino, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
August 17, 2017
Quality of life of people living with HIV compared with that of the general population in Japan
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
International Journal of STD & AIDS
|
November 16, 2019
Decreased levels of urinary liver-type fatty acid-binding protein after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 13, 2016
A Naphthalimide-Based Cd(2+) Fluorescent Probe with Carbamoylmethyl Groups Working as Chelators and PET-Promoters under Neutral Conditions
Koji Tsukamoto, Shota Shimabukuro, Miyuki Mabuchi, et al.
Infectious Diseases (London, England)
|
August 26, 2017
Utility of estimated glomerular filtration rate based on cystatin C in patients receiving combination antiretroviral therapy including dolutegravir
Shinichi Hikasa, Kyoko Hideta, Shota Shimabukuro, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
December 13, 2021
Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on estimated glomerular filtration rate slope in patients with HIV: A retrospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
International Journal of STD & AIDS
|
August 18, 2018
Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Current HIV Research
|
March 28, 2023
Changes in Leptin to Adiponectin Ratio After Antiretroviral Therapy: A Pilot Observational Study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Journal of Pharmaceutical Health Care and Sciences
|
June 12, 2019
Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
HIV Medicine
|
September 20, 2022
Comparison between the impact of tenofovir alafenamide and that of abacavir on rapid kidney function decline: A retrospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
February 9, 2018
A potential drug interaction between phenobarbital and dolutegravir: A case report
Shinichi Hikasa, Akihiro Sawada, Hitomi Seino, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
August 17, 2017
Quality of life of people living with HIV compared with that of the general population in Japan
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
International Journal of STD & AIDS
|
November 16, 2019
Decreased levels of urinary liver-type fatty acid-binding protein after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study
Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, et al.
Page
of 2